NFG
ALT icon

Northeast Financial Group’s Altimmune ALT Stock Holding History

Northeast Financial Group’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42K Buy
13,641
+248
+2% +$1.05K 0.01% 90
2025
Q4 		$48.3K Buy
+13,393
New +$58.4K 0.01% 98

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northeast Financial Group's ALT Position: Q1 2026 in Review

Northeast Financial Group increased its Altimmune (ALT) stake by 1.9% in Q1 2026, buying an estimated $1.05K and bringing the position to 13,641 shares worth $42K. The position accounts for 0.01% of the portfolio, ranked #90.

Northeast Financial Group first reported a position in ALT in Q4 2025 and has held it in 2 quarters since. The position peaked at $48.3K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Northeast Financial Group held 13,641 shares of Altimmune worth $42K as of Q1 2026.
  • Northeast Financial Group bought 248 Altimmune shares in Q1 2026, an estimated $1.05K.
  • Altimmune made up 0.01% of Northeast Financial Group's portfolio in Q1 2026, its #90 holding.
  • Northeast Financial Group first reported a position in Altimmune in Q4 2025 and has held it in 2 quarters since.
  • Northeast Financial Group's Altimmune position peaked at $48.3K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Northeast Financial Group's 13F filing for Q1 2026, filed 15 May 2026.